AARDVARK THERAPEUTICS INC
AARD · NASDAQ
Updated at 2026-10-14 09:17:16
- Today's High
- $4.63
- Today’s Low
- $4.03
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.81
- Previous Close
- $4.45
- Volume
- 99.86K
- Market Cap
- $97.38M
- P/E Ratio
- --
- EPS
- $-3.20
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO, CA, UNITED STATES, 92122
- Country
- US
- Listing Date
- 2025-02-13
- Fiscal Year End
- December
- Shares Outstanding
- 21.88M
- CIK
- --
- Website
- aardvarktherapeutics.com
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$15.08M
2026-03-31
$22.46M
2025-12-31
$18.7M
2025-09-30
$17.7M
Net Income
2026-06-30
-$14.38M
2026-03-31
-$21.58M
2025-12-31
-$17.59M
2025-09-30
-$16.31M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.66
2026-03-31
$-0.99
2025-12-31
$-0.81
2025-09-30
$-0.75
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$14.37M
2026-03-31
-$21.57M
2025-12-31
-$17.58M
2025-09-30
-$16.3M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $15.08M | $22.46M | $18.7M | $17.7M |
| Net Income | -$14.38M | -$21.58M | -$17.59M | -$16.31M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.66 | $-0.99 | $-0.81 | $-0.75 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$14.37M | -$21.57M | -$17.58M | -$16.3M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.